Collaborative care for bipolar disorder: Part II. Impact on clinical outcome, function, and costs

Psychiatric Services

Volumn 57, Issue 7, 2006, Pages 937-945

  Bauer, Mark S ^a,b   McBride, Linda ^a   Williford, William O ^c,d   Glick, Henry ^e   Kinosian, Bruce ^e,f   Altshuler, Lori ^g   Beresford, Thomas ^h   Kilbourne, Amy M ^f   Sajatovic, Martha ⁱ   Brown, George ^j   Eilers, Steven G ^k   Evans, Denise ^l   Fenn, Howard ^m   Hauger, Richard ^f   Kirk, Gail F ⁿ   Mayeda, Aimee ^o   Tekell, Janet ^p   Akiskal, Hagop S ^f   Collins, Joseph F ^d,n   Biswas, Kousick ⁿ   Staves, Pamela ^q   Lavori, Philip ^m   more..

^a PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

^c VA Cooperative Studies Program   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

ⁱ CASE WESTERN RESERVE UNIVERSITY   (United States)

^j James H Quillen VA Medical Center   (United States)

^k UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^l MEDICAL COLLEGE OF GEORGIA   (United States)

^m STANFORD UNIVERSITY   (United States)

ⁿ VA Cooperative Studies Program Coordinating Center   (United States)

^o INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^p UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^q Denver VAMC and VISN 19 MIRECC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; TRANQUILIZER;

ARTICLE; BIPOLAR DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST; DECISION MAKING; FOLLOW UP; HEALTH CARE ACCESS; HUMAN; MAJOR CLINICAL STUDY; MANAGEMENT; MODEL; MULTICENTER STUDY; NURSE; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT SATISFACTION; PRACTICE GUIDELINE; PSYCHOEDUCATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SKILL; SOCIAL LEARNING;

EID: 33745824648     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.2006.57.7.937     Document Type: Article

References (70)

1. Bauer MS, McBride L, Williford WO, et al: Collaborative care for bipolar disorder: part I. intervention and implementation in a randomized effectiveness trial. Psychiatric Services 57:927-936, 2006
2. American Psychiatric Association: Practice guideline for the treatment of patients with bipolar disorder. American Journal of Psychiatry 159:S1-S50, 2002
3. Institute of Medicine: Assessing Medical Technologies. Washington, DC, National Academy Press, 1985
4. Committee on Quality Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, DC, National Academy Press, 2001
5. Bauer MS, Williford W, Dawson E, et al: Principles of effectiveness trials and their implementation in VA Cooperative Study #430, "Reducing the Efficacy-Effectiveness Gap in Bipolar Disorder." Journal of Affective Disorders 67:61-78, 2001
6. Glasgow RE, Lichtenstein E, Marcus AC: Why don't we see more translation of health promotion research to practice? Rethinking the efficacy-to- effectiveness transition. American Journal of Public Health 93:1261-1267, 2003
7. Greenwald P, Cullen JW: The new emphasis in cancer control. Journal of the National Cancer Institute 74:543-551, 1985
8. Flay BR: Efficacy and effectiveness trials (and other phases of research) in the development of health promotion programs. Preventive Medicine 15:451-474, 1986
9. Clark GN: Improving the transition from basic efficacy research to effectiveness studies: methodological issues and procedures. Journal of Consulting and Clinical Psychology 63:718-725, 1995
10. Wells K: Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research. American Journal of Psychiatry 156:5-10, 1999
11. Nierenberg AA, Ostacher MJ, Calabrese JR, et al: Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone. American Journal of Psychiatry 163:210-216, 2006
12. Lieberman JA, Stroup TS, McEvoy JP, et al: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 353:1209-1223, 2006
13. Rush AJ, Trivedi MH, Wisniewski SR, et al: Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. New England Journal of Medicine 354:1231-1242, 2006
14. Trivedi MH, Fava M, Wisniewski SR, et al: Medication augmentation after the failure of SSRIs for depression. New England Journal of Medicine 354:1243-1252, 2006
15. Bodenheimer T, Wagner EJ, Grumbach K: Improving primary care for patients with chronic illness: the chronic care model, part 2. JAMA 288:1909-1914, 2002
16. Von Korff M, Gruman J, Schaefer J, et al: Collaborative management of chronic illness. Annals of Internal Medicine 127:1097-1102, 1997
17. Wagner EH: The role of patient care teams in chronic disease management. British Medical Journal 320:569-572, 2000
18. Badamgarav E, Weingarten SR, Henning JM, et al: Effectiveness of disease management programs in depression. American Journal of Psychiatry 160:2080-2090, 2003
19. Sherbourne CD, Wells KB, Duan N, et al: Long-term effectiveness of disseminating quality improvement for depression in primary care. Archives of General Psychiatry 58:696-703, 2001
20. Unützer J, Rubenstein L, Katon WJ, et al: Two-year effects of quality improvement programs on medication management for depression. Archives of General Psychiatry 58:935-942, 2001
21. Simon GE, Katon WJ, Von Korff M, et al: Cost-effectiveness of a collaborative care program for primary care patients with persistent depression. American Journal of Psychiatry 158:1638-1644, 2001
22. Burns BJ, Santos AB: Assertive community treatment: an update of randomized trials. Psychiatric Services 46:669-675, 1995
23. Rosenheck RA, Neale M: Cost-effectiveness of intensive psychiatric community care for high users of inpatient services. Archives of General Psychiatry 55:459-466, 1998
24. Salkever D, Domino ME, Burns BJ, et al: Assertive community treatment for people with severe mental illness: the effect on hospital use and costs. Health Services Research 34:577-601, 1999
25. Deci PA, Santos AB, Hiott DW, et al: Dissemination of assertive community treatment programs. Psychiatric Services 46:676-678, 1995
26. Phillips SD, Burns BJ, Edgar ER, et al: Moving assertive community treatment into standard practice. Psychiatric Services 52:771-779, 2001
27. Schoenwald SK, Hoagwood K: Effectiveness, transportability, and dissemination of interventions. Psychiatric Services 52:1190-1197, 2001
28. Lam DH, Watkins ER, Hayward P, et al: A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder. Archives of General Psychiatry 60:145-152, 2003
29. Lam DH, Hayward P, Watkins ER, et al: Relapse prevention in patients with bipolar disorder: cognitive therapy outcome after 2 years. American Journal of Psychiatry 162:324-329, 2005
30. Ball JR, Mitchell PB, Corry JC, et al: A randomized controlled trial of cognitive therapy for bipolar disorder: focus on long-term change. Journal of Clinical Psychiatry 67:277-286, 2006
31. Scott J, Paykel E, Morriss R, et al: Cognitive-behavioural therapy for severe and recurrent bipolar disorders: a randomized controlled trial. British Journal of Psychiatry 188:313-320, 2006
32. Miklowitz DJ, George EL, Richards JA, et al: A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Archives of General Psychiatry 60:904-912, 2003
33. Perry A, Tarder N, Morriss R, et al: Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. British Medical Journal 318:149-153, 1999
34. Colom F, Vieta E, Martinez-Aran A, et al: A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Archives of General Psychiatry 60:402-407, 2003
35. Lam DH, McCrone P, Wright K, et al: Cost-effectiveness of relapse-prevention cognitive therapy for bipolar disorder: 30-month study. British Journal of Psychiatry 186:500-506, 2005
36. Bauer MS: The collaborative practice model for bipolar disorder: design and implementation in a multi-site randomized controlled trial. Bipolar Disorders 3:233-244, 2001
37. Bauer MS, McBride L, Shea N, et al: Impact of an easy-access VA clinic-based program for patients with bipolar disorder. Psychiatric Services 48:491-496, 1997
38. Simon GE, Ludman EJ, Bauer MS, et al: Long-term effectiveness and cost of a systematic care management program for bipolar disorder. Archives of General Psychiatry, 63:500-508, 2006
39. First MB, Spitzer RL, Gibbon M, et al: Structured Clinical Interview for Axis I DSM-IV Disorders-(SCID). Patient ed, version 2.0. New York, Biometrics Research Department, New York Psychiatric Institute, 1996
40. Keller M, Lavori P, Friedman B: The longitudinal interval follow-up evaluation. Archives of General Psychiatry 44:540-548, 1987
41. Bauer MS, Kirk G, Gavin C, et al: Determinants of functional outcome and health care costs in bipolar disorder: a high-intensity follow-up study. Journal of Affective Disorders 65:231-241, 2001
42. Glaser W, Aaronson H, Prusoff B, et al: Assessment of social adjustment in chronic ambulatory schizophrenics. Journal of Nervous and Mental Disease 168:493-497, 1980
43. Stewart A, Hays R, Ware J: The MOS short-form general health survey. Medical Care 26:724-735, 1988
44. Nabati L, Shea N, McBride L, et al: Adaptation of a simple patient satisfaction survey to mental health. Psychiatry Research 77:51-56, 1998
45. Keller M, Lavori P, Klerman GL, et al: Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients. Archives of General Psychiatry 43:458-466, 1986
46. Bauer MS, McBride L: Structured Group Psychotherapy for Bipolar Disorder. New York, Springer, 1996
47. Bauer MS, McBride L, Chase C, et al: Manual-based group psychotherapy for bipolar disorder: a feasibility study. Journal of Clinical Psychiatry 59:449-455, 1998
48. Yatham LN, Kennedy SH, O'Donovan C, et al: Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disorders 7(suppl 3):5-69, 2005
49. Bauer MS, Callahan A, Jampala C, et al: Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs. Journal of Clinical Psychiatry 60:9-21, 1999
50. Vojta C, Kinosian B, Glick H, et al: Self-reported quality of life across mood states in bipolar disorder. Comprehensive Psychiatry 42:190-195, 2001
51. Gold MR, Siegel JE, Russell LB, et al: Cost-Effectiveness in Health and Medicine. New York, Oxford University Press, 1996
52. Mallinckrodt CH, Clark WS, David SR: Accounting for dropout bias using mixed-effects models. Journal of Biopharmacological Statistics 11:9-21, 2001
53. Feise R: Do multiple outcome measures require p-value adjustment? BMC Medical Research Methodology 2:1-4, 2002. Available at epub: doi:10.1186/1471-2288-2-8
54. Kraemer HC, Kupfer DJ: Size of treatment effects and their importance to clinical research and practice. Biological Psychiatry, in press 2006 [epub 12/17/05]
55. Katon W, Von Korff M, Lin E, et al: Collaborative management to achieve treatment guidelines. JAMA 273:1026-1031, 1995
56. Diggle PJ, Liang KY, Zeger SL: Analysis of Longitudinal Data. Oxford, England, Clarendon Press, 1994
57. Lin DY, Feuer EJ, Etzioni R, et al: Estimating medical costs from incomplete follow-up data. Biometrics 53:113-128, 1997
58. Efron B, Tibshirani RJ: An Introduction to the Bootstrap. New York, Chapman and Hall, 1993
59. Bauer MS: Bipolar (manic-depressive) disorder, in Psychiatry, 2nd ed. Edited by Tasman A, Kay J, Lieberman J. Philadelphia, Saunders, 2003
60. Simon GE, Ludman EJ, Unützer J, et al: Design and implementation of a randomized trial evaluating systematic care for bipolar disorder. Bipolar Disorders 4:226-236, 2002
61. Suppes T, Rush JA, Dennehy EB, et al: Texas Medication Algorithm Project: clinical results for patients with a history of mania. Journal of Clinical Psychiatry 64:370-382, 2003
62. Calabrese JR, Bowden CL, Sachs G, et al: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. Journal of Clinical Psychiatry 64:1013-1024, 2003
63. Bowden CL, Calabrese JR, Sachs G, et al: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Archives of General Psychiatry 60:392-400, 2003
64. Kessing LV, Andersen PK: Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? Journal of Neurology, Neurosurgery, and Psychiatry 75:1662-1666, 2004
65. Cohen J: Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Edited by Cohen J. Hillsdale, NJ, Erlbaum, 1977
66. Schall MW, Duffy T, Krishnamurthy A, et al: Improving patient access to the Veterans Health Administration's primary care and specialty clinics. Joint Commission Journal on Quality and Safety 30:415-424, 2004
67. Glick HA, Kinosian B, McBride L, et al: Clinical nurse specialist care managers' time commitments in a disease management program for bipolar disorder. Bipolar Disorders 6:452-459, 2004
68. Frank E, Swartz HA, Mallinger AG, et al: Adjunctive psychotherapy for bipolar disorder: effects of changing treatment modality. Journal of Abnormal Psychology 108:579-587, 1999
69. Rosenheck R, Neale M: Intersite variation in the impact of intensive psychiatric community care on hospital use. American Journal of Orthopsychiatry 68:191-200, 1998
70. Kendrick T: Depression management clinics in general practice? Some aspects lend themselves to the mini-clinic approach. British Medical Journal 320:527-528, 2000